On Tuesday, Twist Bioscience Corp (NASDAQ: TWST) opened higher 0.62% from the last session, before settling in for the closing price of $50.30. Price fluctuations for TWST have ranged from $24.15 to $60.90 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 42.89% annually for the last half of the decade. Company’s average yearly earnings per share was noted 36.36% at the time writing. With a float of $56.32 million, this company’s outstanding shares have now reached $58.88 million.
In an organization with 923 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 42.61%, operating margin of -70.56%, and the pretax margin is -66.45%.
Twist Bioscience Corp (TWST) Insider Updates
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Twist Bioscience Corp is 5.12%, while institutional ownership is 110.07%. The most recent insider transaction that took place on Nov 25 ’24, was worth 34,871. In this transaction Chief Accounting Officer of this company sold 789 shares at a rate of $44.20, taking the stock ownership to the 44,831 shares. Before that another transaction happened on Nov 25 ’24, when Company’s Officer proposed sale 789 for $44.20, making the entire transaction worth $34,871.
Twist Bioscience Corp (TWST) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.75 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.77) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.61 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.36% per share during the next fiscal year.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Check out the current performance indicators for Twist Bioscience Corp (TWST). In the past quarter, the stock posted a quick ratio of 4.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.60, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -1.69 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Let’s dig in a bit further. During the last 5-days, its volume was 0.67 million. That was inferior than the volume of 0.95 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 96.10%. Additionally, its Average True Range was 2.59.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 57.63%, which indicates a significant decrease from 97.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.57% in the past 14 days, which was higher than the 70.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.98, while its 200-day Moving Average is $43.06. However, in the short run, Twist Bioscience Corp’s stock first resistance to watch stands at $51.43. Second resistance stands at $52.24. The third major resistance level sits at $53.57. If the price goes on to break the first support level at $49.29, it is likely to go to the next support level at $47.96. Assuming the price breaks the second support level, the third support level stands at $47.15.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
There are currently 59,356K shares outstanding in the company with a market cap of 3.00 billion. Presently, the company’s annual sales total 312,970 K according to its annual income of -208,730 K. Last quarter, the company’s sales amounted to 84,710 K and its income totaled -34,650 K.
